Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

BACKGROUND: There is the need to identify new prognostic markers to refine risk stratification for HER2-positive early breast cancer patients. The aim of this study was to evaluate the association of tumor-infiltrating lymphocytes (TILs) with distant disease-free survival (DDFS) in patients with HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Dieci, M V, Conte, P, Bisagni, G, Brandes, A A, Frassoldati, A, Cavanna, L, Musolino, A, Giotta, F, Rimanti, A, Garrone, O, Bertone, E, Cagossi, K, Sarti, S, Ferro, A, Piacentini, F, Maiorana, A, Orvieto, E, Sanders, M, Miglietta, F, Balduzzi, S, D’Amico, R, Guarneri, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442655/
https://www.ncbi.nlm.nih.gov/pubmed/30657852
http://dx.doi.org/10.1093/annonc/mdz007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442655/
https://www.ncbi.nlm.nih.gov/pubmed/30657852
http://dx.doi.org/10.1093/annonc/mdz007

Ejemplares similares